242 related articles for article (PubMed ID: 24807167)
1. Inhibition of OATP-1B1 and OATP-1B3 by tyrosine kinase inhibitors.
Khurana V; Minocha M; Pal D; Mitra AK
Drug Metabol Drug Interact; 2014; 29(4):249-59. PubMed ID: 24807167
[TBL] [Abstract][Full Text] [Related]
2. Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors.
Khurana V; Minocha M; Pal D; Mitra AK
Drug Metabol Drug Interact; 2014; 29(3):179-90. PubMed ID: 24643910
[TBL] [Abstract][Full Text] [Related]
3. Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).
Roth M; Araya JJ; Timmermann BN; Hagenbuch B
J Pharmacol Exp Ther; 2011 Nov; 339(2):624-32. PubMed ID: 21846839
[TBL] [Abstract][Full Text] [Related]
4. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
[TBL] [Abstract][Full Text] [Related]
5. Pre-incubation with OATP1B1 and OATP1B3 inhibitors potentiates inhibitory effects in physiologically relevant sandwich-cultured primary human hepatocytes.
Farasyn T; Pahwa S; Xu C; Yue W
Eur J Pharm Sci; 2021 Oct; 165():105951. PubMed ID: 34311070
[TBL] [Abstract][Full Text] [Related]
6. Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated Uptake.
Hove VN; Anderson K; Hayden ER; Pasquariello KZ; Gibson AA; Shen S; Qu J; Jin Y; Miecznikowski JC; Hu S; Sprowl JA
Mol Pharmacol; 2022 Jun; 101(6):381-389. PubMed ID: 35383108
[TBL] [Abstract][Full Text] [Related]
7. Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.
Treiber A; Schneiter R; Häusler S; Stieger B
Drug Metab Dispos; 2007 Aug; 35(8):1400-7. PubMed ID: 17496208
[TBL] [Abstract][Full Text] [Related]
8. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.
Gui C; Miao Y; Thompson L; Wahlgren B; Mock M; Stieger B; Hagenbuch B
Eur J Pharmacol; 2008 Apr; 584(1):57-65. PubMed ID: 18321482
[TBL] [Abstract][Full Text] [Related]
9. Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1.
Annaert P; Ye ZW; Stieger B; Augustijns P
Xenobiotica; 2010 Mar; 40(3):163-76. PubMed ID: 20102298
[TBL] [Abstract][Full Text] [Related]
10. Interactions of crizotinib and gefitinib with organic anion-transporting polypeptides (OATP)1B1, OATP1B3 and OATP2B1: gefitinib shows contradictory interaction with OATP1B3.
Sato T; Ito H; Hirata A; Abe T; Mano N; Yamaguchi H
Xenobiotica; 2018 Jan; 48(1):73-78. PubMed ID: 28005438
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of a three-way drug interaction between danoprevir, ritonavir and the organic anion transporting polypeptide (OATP) inhibitor ciclosporin.
Brennan BJ; Moreira SA; Morcos PN; Navarro MT; Asthappan J; Goelzer P; Weigl P; Smith PF
Clin Pharmacokinet; 2013 Sep; 52(9):805-13. PubMed ID: 23712757
[TBL] [Abstract][Full Text] [Related]
12. Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Karlgren M; Vildhede A; Norinder U; Wisniewski JR; Kimoto E; Lai Y; Haglund U; Artursson P
J Med Chem; 2012 May; 55(10):4740-63. PubMed ID: 22541068
[TBL] [Abstract][Full Text] [Related]
13. Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3.
Herfindal L; Krakstad C; Myhren L; Hagland H; Kopperud R; Teigen K; Schwede F; Kleppe R; Døskeland SO
PLoS One; 2014; 9(4):e94926. PubMed ID: 24740327
[TBL] [Abstract][Full Text] [Related]
14. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.
Vavricka SR; Van Montfoort J; Ha HR; Meier PJ; Fattinger K
Hepatology; 2002 Jul; 36(1):164-72. PubMed ID: 12085361
[TBL] [Abstract][Full Text] [Related]
15. Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions.
Farasyn T; Crowe A; Hatley O; Neuhoff S; Alam K; Kanyo J; Lam TT; Ding K; Yue W
J Pharm Sci; 2019 Oct; 108(10):3443-3456. PubMed ID: 31047942
[TBL] [Abstract][Full Text] [Related]
16. Octreotide inhibits the bilirubin carriers organic anion transporting polypeptides 1B1 and 1B3 and the multidrug resistance-associated protein 2.
Visentin M; Stieger B; Merz M; Kullak-Ublick GA
J Pharmacol Exp Ther; 2015 Nov; 355(2):145-51. PubMed ID: 26330539
[TBL] [Abstract][Full Text] [Related]
17. Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III.
Bednarczyk D; Boiselle C
Xenobiotica; 2016; 46(5):457-66. PubMed ID: 26383540
[TBL] [Abstract][Full Text] [Related]
18. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
19. Interaction of human organic anion transporter polypeptides 1B1 and 1B3 with antineoplastic compounds.
Marada VV; Flörl S; Kühne A; Burckhardt G; Hagos Y
Eur J Med Chem; 2015 Mar; 92():723-31. PubMed ID: 25618019
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3.
Bednarczyk D
Anal Biochem; 2010 Oct; 405(1):50-8. PubMed ID: 20540932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
